Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Sars-Cov-2 Omicron (B.1.1.529) Variant: No Time to Wait! Publisher Pubmed



Rahmani S1, 2 ; Rezaei N2, 3, 4
Authors

Source: Acta Biomedica Published:2022


Abstract

On November 26th, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.1.529, was designated by the World Health Organization (WHO) as a variant of concern (VOC) and named Omicron. The news raised an international alarm about a new wave of coronavirus disease 2019 (Covid-19) outbreak, since Omicron has a large group of mutations, which may affect the way it spread, cause disease, and escape from the immunity. Therefore, it is essential to take a closer look at how it has emerged, how it may sustain the pandemic, and how we can act correspondingly, both nationally and internationally, to help controlling the spread of the disease. (www.actabiomedica.it). © Mattioli 1885.
Other Related Docs
4. Modern Diagnostics Processes Among New Strains of Coronaviruses: A Review, Journal of Datta Meghe Institute of Medical Sciences University (2022)
8. Covid-19 Pandemic: The Influence of Culture and Lessons for Collaborative Activities, Advances in Experimental Medicine and Biology (2021)
10. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
13. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
14. Health Care Policies and Covid-19 Prevalence: Is There Any Association?, International Journal of Health Services (2022)
15. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)